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The mammalian hair follicle is a highly dynamic
skin appendage that undergoes repeated cycles of
growth and regression, involving closely co-ordi-
nated regulation of cell proliferation, differentiation,
and apoptosis. The Myc superfamily of transcription
factors have been strongly implicated in the regula-
tion of these processes in many tissues. Using immu-
nohistochemistry, we have investigated the patterns
of c-Myc, N-Myc, Max, and Mad1±4 expression at
different stages of the human hair growth cycle. N-
Myc, Max, Mad1, and Mad3 immunoreactivity was
detected in the epidermis and the epithelium of both
anagen and telogen hair follicles. Three distinct pat-
terns of hair follicle c-Myc immunoreactivity were
observed. In the infundibulum, c-Myc staining was
predominantly in the basal layers, with little detect-
able immunoreactivity in the terminally differentiat-
ing suprabasal layers; this pattern was similar to that
seen in the epidermis. In contrast, c-Myc expression
in the follicle bulb was found both in the proliferat-
ing germinative epithelial cells and in the terminally
differentiating matrix cells that give rise to the hair
®ber. Finally, intense c-Myc immunoreactivity was
detected in the bulge region of the outer root sheath.
Using the C8/144B antibody as a bulge marker, we
con®rmed that c-Myc immunoreactivity in the outer
root sheath correlates with the putative hair follicle
stem cell compartment. c-Myc expression in the
bulge was independent of the hair growth cycle
stage. Our data suggest that Myc superfamily mem-
bers serve different functions in separate epithelial
compartments of the hair follicle and may play an
important role in determining cell fate within the
putative stem cell compartment. Key words: bulge/
hair cycle/immunohistochemistry. J Invest Dermatol
116:617±622, 2001
T
he mammalian hair follicle is a complex, highly
compartmentalized structure composed of both
epithelial components [the germinative epithelium,
matrix, inner root sheath (IRS), and outer root sheath
(ORS)] and dermal components [the dermal papilla
(DP) and connective tissue sheath (CTS)]. Hair growth is cyclical
and involves repeated phases of cell proliferation, differentiation,
and apoptosis (for review, see Paus and Cotsarelis, 1999). Three
distinct stages of the hair cycle have been identi®ed: an active
growth stage, anagen, during which hair growth is effected by
proliferation of the germinative epithelium, giving rise to
concentric layers of matrix cells that undergo lineage restricted
differentiation to form the component structure of the hair ®ber
and its root sheaths; a regressive catagen stage in which the follicle
undergoes apoptosis, resulting in the formation of a much smaller
resting telogen follicle that then re-enters anagen.
The Myc superfamily of proteins are a group of related basic
helix-loop helix leucine zipper transcription factors that include
Myc, Max, and Mad protein subfamilies (for reviews see Chin et al,
1996; Ryan and Birnie, 1996; Obaya et al, 1999; Schmidt, 1999).
Most functions of the Myc subfamily are mediated via the
formation of heterodimers with Max (reviewed in Sakamuro and
Prendergast, 1999). Myc and Max heterodimers are able to bind to
DNA and regulate the transcription of target genes that in turn
regulate proliferation, and apoptosis (for reviws, see Cole and
McMahon, 1999; Prendergast, 1999). Max can also form hetero-
dimers with Mad proteins. Currently four members of the Mad
subfamily have been identi®ed, which have all been implicated in
growth arrest and differentiation (Hurlin et al, 1995b; Vastrik et al,
1995).
c-Myc has been implicated in a number of cutaneous diseases,
including psoriasis, melanoma, and HPV-associated skin tumors
(Elder et al, 1990; Osterland et al, 1990; Hurlin et al, 1995a;
Schlagbauer-Wadl et al, 1999). In normal human skin, immuno-
histochemistry has shown that c-Myc is expressed in the
proliferative basal layers of the epidermis, but is absent in the
suprabasal, terminally differentiating cells (Osterland et al, 1990). In
vitro studies have shown that proliferation of keratinocytes is
inhibited by c-Myc antisense treatment (Pietenpol et al, 1990) and
that TPA-induced differentiation of primary human keratinocytes,
results in downregulation of c-Myc and upregulation of mad1 steady
state mRNA levels. This suggests that in skin c-Myc is an important
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regulator of keratinocyte proliferation and that downregulation of
c-Myc is associated with terminal differentiation.
Although c-Myc and other superfamily members have been
reported in skin, there is little information on their localization or
possible role in the hair follicle. Since members of the Myc
superfamily have been implicated in the regulation of cell
proliferation, differentiation, and apoptosis, it is likely that they
also play a key role in biology of the hair follicle. To investigate
this, we have studied the patterns of expression of members of the
Myc superfamily (c-Myc, N-Myc, Max, Mad1, Mad2, Mad3,
Mad4) in human hair follicles and at different stages of the human
hair growth cycle.
MATERIALS AND METHODS
Tissue preparation Redundant hair-bearing human scalp skin was
obtained from patients undergoing facelift operations (ethical committee
permission was given), immediately ®xed in 10% formalin and embedded
in paraf®n. Longitudinal sections (4±5 mm thickness) of hair follicles
were cut and mounted on Superfrost Plus microscope slides.
Immunohistochemistry Speci®c anti-human c-Myc mouse
monoclonal antibody (9e10), rabbit polyclonal antibodies against N-Myc
(C-19), Mad1 (C-19), and Mad3 (H-206), and goat polyclonal antibodies
against Mad2 (C-17) and Mad4 (D-19) were used (Santa Cruz
Biotechnology, CA). The C8/144B mouse monoclonal antibody and the
Ki67 rabbit polyclonal antibody were purchased from Dako (Cambridge,
U. K. ). Staining was enhanced by boiling slides in 10 mM citrate buffer
(pH 6) for 8 min. Non-speci®c binding was minimized by treating
sections with normal horse serum for 20 min. Primary antibodies were
diluted in 0. 2% bovine serum albumin in 5 mM tris-buffered saline
(TBS) at pH 7. 6, at the following dilutions: c-Myc (1:100), N-Myc
(1:75), Max (1:50), Mad1 (1:500), Mad2 (1:25), Mad3 (1:150), Mad4
(1:25), and C8/144B (1:25) and incubated overnight at 4°C. Sections
were then washed in TBS and incubated with a biotinylated horse
secondary antibody (Vector Laboratories, Burlingame, CA) for 45 min at
room temperature. Following further washes in TBS, sections were
incubated with avidin-biotin alkaline phosphatase complex (Vector
Laboratories) for 45 min; then washed in TBS and the color developed
with alkaline phosphatase substrate (Vector Laboratories). Sections were
then counterstained in Gill's hematoxylin, dehydrated, and mounted in
DePeX mountant (Sigma, Poole, U. K. ). Control experiments were
carried out in which the primary antibody was either preincubated with
blocking peptide or was omitted from the staining procedure. Each
antibody was tested on facelift skin from at least ®ve different patients,
with the immunoreactivity patterns from at least 10 anagen and three
telogen hair follicles investigated per patient. For c-Myc/Ki67 double
staining, sections were ®rst stained for c-Myc as described above, then
treated with normal swine serum for 20 min. Ki67 antibody (1:600) was
incubated overnight at 4°C. Sections were then washed in TBS and
incubated with a swine antirabbit HRP conjugate (Dako) for 45 min at
room temperature. Following a further wash in TBS, color was
developed with 3,3¢-diaminobenzidine (DAB) substrate (Biogenex, San
Ramon, CA). Slides were subsequently counterstained, dehydrated, and
mounted as described above.
RESULTS
Immunoreactivity for speci®c myc superfamily members is
detected in all epithelial compartments of the hair
follicle We have investigated the immunoreactivity patterns
of speci®c Myc superfamily members at different stages of the
human hair growth cycle. Using formalin-®xed paraf®n-embedded
sections, we detected nuclear staining for c-Myc, N-Myc, Max,
Mad1, and Mad3 in all hair follicle epithelial compartments.
Furthermore, immunoreactivity for these transcription factors was
also detected in the epidermis and the sweat glands (data not
shown). No staining for either Mad2 or Mad4 was detected in hair
follicles (data not shown).
Strong immunoreactivity for c-Myc is detected in the bulge
region of human hair follicles The bulge is a region of the
ORS, situated below the sebaceous duct and close to the insertion
of the arrector pili muscle, and is believed to contain hair follicle
stem cells (Cotsarelis et al, 1990; Lyle et al, 1998). Restricted to this
location, we observed intense c-Myc immunoreactivity in nuclei of
keratinocytes in the basal layers, using the mouse, antihuman c-
Myc, monoclonal antibody, 9E10. In contrast, the ORS further
towards the follicle bulb was consistently negative for c-Myc
immunoreactivity (see Fig 1a). As the bulge is often
indistinguishable from the adjacent ORS, we have used the
mouse monoclonal antibody C8/144B, which has been reported to
be a good marker for the bulge in human follicles (Lyle et al, 1998).
Using serial sections, we have compared the immunoreactivity
patterns of 9E10 and C8/144B. Figure 1(a) and 1(b) show that the
region of immunoreactivity detected with the 9E10 (c-Myc)
antibody correlates with that stained by the C8/144B antibody;
however, Fig 1(a) and 1(b) also illustrate that C8/144B
immunoreactivity extends slightly further towards the follicle
bulb than c-Myc immunoreactivity. Therefore the c-Myc-
positive cells appear to be a subpopulation of the C8/144B-
positive cells. Figure 1(c) shows that while there is weak
cytoplasmic c-Myc immunoreactivity in the suprabasal layers,
intense nuclear c-Myc immunoreactivity is observed in the basal
layers. Figure 1(d) demonstrates the cytoplasmic C8/144B
immunoreactivity in the ORS from the subsequent section of the
same hair follicle. Within the c-Myc/C8144B-positive region of
the bulge, we frequently found a small subpopulation of c-Myc
negative cells (Fig 1e). Not all follicle sections stained contained c-
Myc-negative cells within the C8/144B-positive region and these
cells will require further investigation. A close correlation between
9E10 and C8/144B immunoreactivity was found irrespective of
hair cycle stage (data not sown). As shown in Fig 1(f) similar
patterns of c-Myc immunoreactivity were also observed in the
more prominent bulge region of vellus follicles.
c-Myc immunoreactivity is found throughout the follicle
bulb in anagen, but is downregulated in telogen follicles In
the interfollicular epidermis and infundibulum, c-Myc immuno-
reactivity was restricted to the basal cell layers. Most cells in the
suprabasal layers of the interfollicular epidermis and infundibulum
were negative for c-Myc (Fig 1g). In contrast, c-Myc immuno-
reactivity in the hair follicle bulb was detected throughout the
follicle bulb epithelium (Fig 1h). In addition, we also detected c-
Myc immunoreactivity in a small number of cells within the DP
and perifollicular CTS (Fig 1h); however, the majority of cells
within the DP and CTS appeared c-Myc negative. In telogen hair
follicles, c-Myc expression was still detected in the basal cells of the
Figure 1. Immunohistochemical analysis reveals that Myc superfamily transcription factors are located in key regions of the human hair
follicle. Positive staining is shown in red, whereas hematoxylin counterstaining is in blue. Parts (a) and (b) show the bulge region in anagen, stained for
c-Myc and C8/144B epitope, respectively (brackets denote stained bulge region), whereas parts (c) and (d) show serial sections of the bulge region at
higher magni®cation, stained for c-Myc and C8/144B epitope, respectively. (e) c-Myc staining of individual cells within the bulge (arrowheads show c-
Myc negative cells with in the C8/144B-positive bulge region). (f±i) c-Myc in (f) bulge of a vellus hair follicle; (g) interfollicular epidermis and
infundibulum; (h) follicle bulb; (i) proximal region of telogen follicle. The staining patterns in the human hair follicle are shown for Mad1 (j±k); Mad3
(l±o); N-Myc (p±s); Max (t±w). Staining for c-Myc, Mad1, Mad3, N-Myc, and Max in (g, l, p, t), interfollicular epidermis and infundibulum (a, m, q, u)
bulge region of anagen follicles (h, j, n, r, v) follicle bulb (i, k, o, s, w) proximal region of a telogen follicle, is illustrated. Double staining for c-Myc and
Ki67 is shown in the central hair follicle (x) and follicle bulb (y). Ki67-positive cells are stained dark brown. Scale bars: (a, b, q, s, y) 140 mm; (c, d, h, j)
60 mm; (e) 40 mm; (f, n) 50 mm; (g, i, k, o, u) 120 mm; (r, v, y) 100 mm; (l, p, t) 110 mm; (m, w) 150 m. dashed line de®ne the borders of APM, ORS,
and SG not clearly visible. In (k), (o), and (w) dashed circles denote location of DP. In (x) arrows show Ki67-positive ORS cells. APM arrector pilli
muscle; B, bulge; CTS connective tissue sheath; DP dermal papilla, E, epidermis; HC, hair canal; HS, hair shaft; HM, hair matrix; INF, infundibulum;
ORS, outer root sheath; SG, sebaceous gland.
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interfollicular epidermis, infundibulum (data not shown), as well as
in the bulge (Fig 1i). In contrast to the abundant c-Myc
immunoreactivity seen in the follicle bulb in anagen hair follicles
(Fig 1h), however, only weak c-Myc immunoreactivity was
detected in the basal epithelial cells adjacent to the DP in telogen
follicles (Fig 1i).
N-Myc, Max, Mad1, and Mad3 are detectable in the
majority of epithelial cells in anagen and telogen hair
follicles Figure 1(j±w) show the immunoreactivity patterns for
other Myc superfamily proteins. Mad1 (Fig 1j, k), Mad3 (Fig 1l±
o), N-Myc (Fig 1p±s), and Max (Fig 1t±w) were detected in all
epithelial layers of the epidermis and hair follicle, during anagen
and telogen. In the follicle bulb, Mad1 (Fig 1j), Mad3 (Fig 1n),
N-Myc (Fig 1r), and Max (Fig 1v) showed similar
immunoreactivity patterns to that seen for c-Myc (Fig 1h). In
each case, immunoreactivity was detected in the germinative
epithelium, matrix (both presumptive hair ®ber and IRS) and in a
subpopulation of cells in the DP and CTS. Whereas c-Myc
expression in the ORS was predominantly basal and restricted to
the bulge, immunoreactivity for Mad1 (data not shown), Mad3
(Fig 1m), N-Myc (Fig 1q), and Max (Fig 1u) was observed in
both the bulge and the ORS extending into the proximal hair
follicle. In the interfollicular epidermis and infundibulum
immunoreactivity for Mad1 (not shown), Mad3 (Fig 1l), N-Myc
(Fig 1p), and Max (Fig 1t) was found in all epithelial layers,
although intensity appeared to vary between individual cells. In
telogen hair follicles, no apparent differences in immunoreactivity
were observed for Mad1 (Fig 1k), Mad3 (Fig 1o), N-Myc
(Fig 1s), and Max (Fig 1w), with widespread epithelial staining
detected. Strong staining for Mad3 (Fig 1m), N-Myc (Fig 1q), and
Max (Fig 1w) was also observed in the nuclei of sebocytes in the
sebaceous gland.
Expression of c-Myc does not correlate with proliferation in
the human hair follicle Since c-Myc is implicated in
keratinocyte proliferation, we performed double-staining for c-
Myc and the proliferation marker Ki67. In anagen hair follicles,
Ki67-positive cells were very rarely observed in the c-Myc-positive
bulge region, while proliferating cells were more frequently
detected in ORS above (not shown) and below this area
(Fig 1x). In the follicle bulb, c-Myc was detected in the
proliferating (Ki67-positive) germinative epithelium and in
terminally differentiating matrix cells that give rise to the hair
®ber and IRS (Fig 1y).
The immunoreactivity patterns of Myc superfamily members are
summarized in Fig 2, which illustrates the contrasting pattern of c-
Myc, N-Myc, Max, Mad1, and Mad3 immunoreactivity in the
epithelium of human anagen hair follicles.
DISCUSSION
In this study we have characterized the patterns of c-Myc, N-Myc,
Max, and Mad expression in the human hair follicle, at different
stages of the hair growth cycle. We observed three distinct patterns
of c-Myc expression: (i) in the infundibulum c-Myc immuno-
reactivity was mainly found in the basal layers with little or no
detectable suprabasal staining (ii) in the ORS c-Myc immuno-
reactivity was also basal, but restricted to a region of the ORS
believed to contain stem cells (iii) in the follicle bulb c-Myc
immunoreactivity was detected in both the proliferating germina-
tive epithelium and the terminally differentiating matrix cells that
give rise to the hair ®ber.
Recently Rumio et al (2000) have described the immunor-
eactivity pattern of c-Myc expression in anagen hair follicles. In
their study the authors reported c-Myc immunoreactivity in two
regions of the IRS, but failed to detect c-Myc in any other follicle
compartment. Moreover, they also failed to detect c-Myc in the
epidermis, which is inconsistent with previous studies (see below).
In contrast, we observed c-Myc expression in other hair follicle
compartments as well as the proximal IRS, which suggests that our
methodology may have greater sensitivity. Rumio et al (2000) did
not investigate other hair cycle stages and did not report the
localization of other Myc superfamily members in the hair follicle.
In mice, c-myc expression in the epidermis and gut is restricted to
tissue compartments that contain actively dividing cells, whereas in
compartments containing terminally differentiating cells, c-myc
expression is either downregulated or absent (Chin et al, 1995;
Hurlin et al, 1995a). Moreover, proliferation of keratinocytes in vitro
is inhibited by c-myc antisense (Pietenpol et al, 1990) and in
transgenic mice, expression of activated c-Myc-estrogen receptor
fusion protein in suprabasal layers results in hyperproliferation of
the epidermis and disruption of epidermal terminal differentiation
(Pelengaris et al, 1999). Our data showing that in the epidermis and
infundibulum, c-Myc immunoreactivity is restricted to cells within
the basal layers is similar to the c-Myc immunoreactivity pattern
previously reported in normal human epidermis (Osterland et al,
1990) and is consistent with the proposed role of c-Myc as a key
regulator of keratinocyte cell proliferation. In contrast to the
staining patterns seen in the epidermis and infundibulum, c-Myc
expression in the hair follicle bulb was observed in both the
germinative epithelium and the terminally differentiating matrix.
The germinative epithelium is a highly proliferative population of
hair follicle epithelial cells and since c-Myc has been strongly
Figure 2. Summary diagram of the localization of Myc
superfamily transcription factors in the human hair follicle.
Schematic representation of c-Myc, N-Myc, Max, Mad1, and Mad3
immunoreactivity in the epithelium of human anagen hair follicles. B,
bulge; E, epidermis; HM, hair matrix; ORS, outer root sheath.
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implicated in regulation of keratinocyte proliferation, it is not
surprising that the germinative epithelium were c-Myc positive.
Cells, within the matrix are committed to undergo terminal
differentiation, however, giving rise to the component structures of
the keratinized hair ®ber and root sheaths, so ®nding these cell
positive for c-Myc was unexpected. In cultured keratinocytes,
TPA-induced differentiation has been reported to result in a
reduction of c-myc mRNA levels (Dotto et al, 1986; Hurlin et al,
1995a). While this is not observed with calcium-induced differen-
tiation (Dotto et al, 1986). Therefore, c-Myc downregulation may
not be essential for hair matrix cells to terminally differentiate.
In addition to its role in regulating cell proliferation, Myc
proteins have also been shown to trigger apoptosis in many
different cell types (for review, see Prendergast, 1999). Evan et al
(1992) have shown that constitutive expression of c-Myc in
®broblasts induces apoptosis unless so-called "survival factors" are
present. One of these key survival factors is insulin-like growth
factor-1 (IGF-I). This is important as IGF-I has been shown to be
an important hair follicle growth factor and withdrawal of IGF-I
from cultured human hair follicles results in an, apoptotic, catagen-
like state (Philpott et al, 1994). Moreover, Rudman et al (1997)
have shown by immunohistochemistry, that in human hair follicles
IGF-I receptor is expressed in both the DP and the matrix and is
regulated in a cycle-dependant manner. Therefore, cycle changes in
IGF-I signaling in vivo could potentially trigger c-Myc-dependent
apoptosis, resulting in catagen.
Although c-Myc showed marked differences in patterns of
expression in different hair follicle compartments, immunoreactiv-
ity for N-Myc, Mad1, Mad3, and Max was uniformly distributed
throughout all epithelial layers. This suggests that N-Myc, Mad1,
Mad3, and Max serve functions different to those of c-Myc in the
hair follicle and that Myc superfamily regulated genes are
modulated by a complex equilibrium between individual family
members. Mad1 has already implicated in epidermal differentiation
(Chin et al, 1995; Hurlin et al, 1995a; Vastrik et al, 1995;
Lymboussaki et al, 1996). Mad3, although detected in the mouse
embryonic epidermis (Hurlin et al, 1995b), has not been previously
reported in human skin. Like Mad1, Mad3 is thought to have a role
in differentiation, so it was therefore unexpected to fund abundant
Mad1 and Mad3 immunoreactivity in proliferative regions of the
hair follicle. We investigated the Mad1 immunoreactivity pattern
again with a second antibody (FL-221, Santa Cruz Biotechnology),
which con®rmed the expression pattern described (data not
shown). In most cell types Max is constitutively expressed
(reviewed in Sakamuro and Prendergast, 1999), which is consistent
with the widespread distribution we observed in the hair follicle,
although many dermal cells were Max-negative. N-Myc shares
most of the functions of c-Myc, although it is not always
downregulated with terminal differentiation (Mugrauer et al,
1988; Nesbit et al, 1999). Therefore, N-Myc may also be involved
in terminal differentiation of the hair follicle epithelium.
We have also characterized expression of Myc superfamily
members at different stages of the human hair growth cycle.
Previous studies using reverse transcriptase-polymerase chain
reaction showed that steady-state levels of c-Myc mRNA are
elevated in murine anagen skin (Seilberg et al, 1995). Our data
indicate that c-Myc protein is present in hair follicles throughout
the growth cycle, although we did observe a reduction in the
intensity of immunoreactivity in the epithelial cells adjacent to the
DP in telogen.
Finally, we observed a very marked, but restricted, pattern of c-
Myc expression in the bulge region of human hair follicles. In mice,
the bulge region of the ORS has been shown to contain a
population of slow cycling, label retaining cells that are believed to
constitute the stem cell population of the hair follicle (Cotsarelis et
al, 1990). In human terminal hair follicles the bulge is not
anatomically visible; however, the mouse monoclonal antibody
C8/144B has been reported to delineate a region of the ORS in
human hair follicles that correlates with the bulge in mice (Lyle et
al, 1998). Moreover, this C8/144B-positive region of the human
hair follicle has been shown to contain a population of slow cycling,
label retaining cells, that display high b1 integrin immunoreactivity
(Lyle et al, 1998) and probably represent a population of human hair
follicle stem cells. In our study we found that nuclear c-Myc
immunoreactivity in the bulge of human hair follicles correlates
with C8/144B staining. This suggests that c-Myc may be involved
in regulating this stem cell compartment. A possible role for c-Myc
in regulating stem cells has been suggested by Gandarillas and Watt
(1997), who showed that when keratinocyte cultures were
enriched for stem cells on the basis of b1 integrin expression,
constitutive c-Myc expression within these enriched cells drove
them into the transit amplifying compartment. Therefore, in
human keratinocytes c-Myc appears to regulate the switch from
stem to transit amplifying cells. This may also be its role in the
putative site of stem cells in the human hair follicle. Moreover, if c-
Myc promotes the exit from stem to transit amplifying cell
compartment, then possibly the subpopulation of c-Myc-negative
cells frequently observed in the c-Myc/C8144B-positive region
may be cells committed to remain in the stem cell compartment,
although this will require further investigation.
In conclusion, we observed a distinct pattern of c-Myc
immunoreactivity in different epithelial compartments of the hair
follicle. These data suggest that c-Myc may have a key role in cell
proliferation in the hair follicle, but may also have separate
functions in nonproliferating cells and play an important role in
determining cell fate within the putative stem cell compartment.
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